The physiological reduction in the production of cholesterol-derived steroid hormones (precursors) by the adrenal glands, notably DHEA and pregnenolone, which are upstream of cortisol and sex hormones. This decline is a common component of age-related changes in the endocrine system, often referred to as adrenopause. Reduced levels of these foundational steroids can impact downstream hormonal balance and overall vitality. Clinical assessment often reveals this trend as part of a comprehensive hormonal profile evaluation.
Origin
The term originates from the field of endocrinology and human physiology, specifically referring to the function of the adrenal cortex. “Adrenal” denotes the gland, “precursor” refers to the foundational steroid molecules like pregnenolone, and “decline” indicates the age-related decrease in synthesis capacity. It describes a key facet of the body’s aging process within the hypothalamic-pituitary-adrenal (HPA) axis.
Mechanism
The primary mechanism involves reduced activity of key enzymes, such as cholesterol side-chain cleavage enzyme (P450scc), within the adrenal cortex’s zona fasciculata and reticularis. This enzymatic slowdown directly limits the conversion of cholesterol into pregnenolone, the initial and rate-limiting step in all steroidogenesis. Consequently, the availability of subsequent precursors like DHEA is diminished, leading to a cascade effect on other hormone levels and cellular functions.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.